Patent · US Expired

Transdermal delivery system

US6274166A · kind A · utility

23Cited by

1References

5Claims

0Family size

Assignee

BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY · IL

Inventors

Amnon Sintov · Ann Arbor, US
Uri Wormser · Jerusalem, IL

Key dates

Filing date	Nov 23, 1999
Grant date	Aug 14, 2001
Priority date	—
Expiry date	Nov 23, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A transdermal delivery system comprising an active ingredient selected from the group consisting of peptides, proteins and mixtures thereof and a pharmaceutically acceptable oxidizing agent. The transdermal delivery system is an easy-to-use topical system that facilitates the penetration of an active ingredient, such as insulin, through the skin layers and into the blood stream. Additionally, the invention includes a method for treating diabetes and other pathologic systemic conditions comprising administering an active ingredient selected from the group consisting of peptides, proteins and mixtures thereof and a pharmaceutically acceptable oxidizing agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.